10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615 | -26.1% | 14,900 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $832 | +4.3% | 14,900 | +4.2% | 0.00% | -20.0% |
| Q1 2023 | $798 | +53.2% | 14,300 | 0.0% | 0.01% | +66.7% |
| Q4 2022 | $521 | -99.9% | 14,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | -37.1% | 14,300 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $647,000 | -35.0% | 14,300 | +9.3% | 0.00% | -33.3% |
| Q1 2022 | $995,000 | -45.2% | 13,082 | +7.4% | 0.01% | -33.3% |
| Q4 2021 | $1,815,000 | +66.5% | 12,182 | +62.8% | 0.01% | +50.0% |
| Q3 2021 | $1,090,000 | -25.6% | 7,484 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $1,466,000 | -36.2% | 7,484 | -41.1% | 0.01% | -38.5% |
| Q1 2021 | $2,299,000 | +18.5% | 12,700 | -7.3% | 0.01% | +8.3% |
| Q4 2020 | $1,940,000 | – | 13,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |